American Society for Bone and Mineral Research Secondary Fracture Prevention Initiative Coalition releases new recommendations to intensify efforts to increase diagnosis and treatment of high-risk individuals amid drop in use of evidence-based therapies and increase in expected number of hip fractures A coalition of bone health experts, physicians, specialists, and patient advocacy groups today released...
CEU Preview: Boning Up – Sessions on Endocrine Disorders of the Bone
From osteoporosis to hypophosphataemic maladies, CEU attendees will become very well versed in endocrine disorders of the bone and skeleton. A few of the speakers gave a glimpse into what their sessions will offer in discussing how to care for patients with common as well as rare bone and mineral conditions. Each year, hundreds of...
Congratulations to the 2018 awardees for this year’s Osteoporosis Fellows Series being held August 1 — 2 in Santa Fe, New Mexico. This two-day conference is designed for clinical endocrine fellows in adult and pediatric programs that are looking to update their knowledge of rare bone diseases and clinical best practices. The faculty will select the top four abstracts presented at the Osteoporosis conference for an additional speaking session at the Santa Fe Bone...
Broken Bones Among Older People Increase Risk of Death for Up to 10 years
Broken bones among older people increase their risk of death for up to 10 years, according to a new study published in The Journal of Clinical Endocrinology & Metabolism. Older people with broken bones face a higher risk of death, and that risk can stay elevated for years. Hip fractures are known to increase the mortality...
Winning Combinations: Sequential Drug Therapy for Osteoporosis
Felicia Cosman, MD, from Columbia University discusses what the results from the ACTIVE and ACTIVExtend trials mean for postmenopausal patients with osteoporosis. Could a combination drug regimen prove to be the answer? The 100th annual meeting of the Endocrine Society, ENDO 2018 in Chicago, set the stage for a number of scientific advancements and progress... The osteoporosis drug alendronate was linked with a reduced risk of cardiovascular death, heart attack, and stroke in a Journal of Bone and Mineral Research study of patients with hip fractures. The association was seen for up to 10 years after fracture. In the study, patients newly diagnosed with hip fracture from 2005 through 2013...
Targeting Cellular Senescence Could Halt Age-Related Bone Loss
Inhibiting cellular senescence could be a novel therapeutic strategy to prevent bone loss and other age-related diseases, according to a mini-review recently published in The Journal of Clinical Endocrinology & Metabolism. Researchers led by Sundeep Khosla, MD, of the Mayo Clinic in Rochester, Minn., write that while life expectancy now is longer than ever, age-related...
A 40-year-old man presents to the emergency department with a 1-week history of progressive weakness of his arms and legs, intermittent cramps in his fingers and feet, and pain in “all of his bones.” These symptoms have limited his activity level. He reports having sharp and dull pain in the bilateral ribs and feet for...
